Pinnacle Pharmaceuticals   Report issue

For profit Phase 2
Founded: Radford VA United States (2007)
Status: Acquired by New River Pharmaceuticals (2011) → now Takeda (2018)

Organization Overview

First Clinical Trial
2011
NCT01406587
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Pinnacle Pharmaceuticals, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

pp4001 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Urinary Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1